Department of Neuroradiology, Cantonal Hospital Aarau, Aarau, Switzerland.
Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland.
J Neurointerv Surg. 2018 Dec;10(12):e31. doi: 10.1136/neurintsurg-2018-013838. Epub 2018 May 17.
Given the promising performance of the new Embolus Retriever with Interlinked Cages (ERIC) in smaller case series, we sought to assess the efficacy and safety of mechanical thrombectomy (MT) with ERIC compared with other stent retrievers (SRs) in acute ischemic stroke due to large vessel occlusion (LVO).
We reviewed the databases of two comprehensive stroke centers in in Germany and Switzerland for MT due to LVO in the anterior circulation with either ERIC or another SR as a first device. Co-primary outcome was defined as successful recanalization (Thrombolysis in Cerebral Infarction 2b/3) after the first device and favorable outcome (modified Rankin Scale score 0-2) at 90 days' follow-up. Multiple logistic regression analysis was applied to adjust for potential confounders.
183 consecutive patients with stroke were treated with either ERIC (49%) or a SR (51%) as the first device and successful recanalization was seen in 82% and 57%, respectively (P<0.001). Adding SR to futile ERIC recanalization or vice versa increased final recanalization rates (ERIC: 87%, SR: 79%). The use of ERIC as a first device resulted in favorable clinical outcome in 50% compared with 35% when a SR was used (P=0.038), an effect driven by age, stroke severity, presence of carotid-T-occlusion, and general anesthesia and not by the device deployed.
The use of ERIC as a first device appeared to be associated with higher rates of successful recanalization and resulted in better functional outcome. However, favorable outcome was not attributable to ERIC. Most importantly, both device types complemented one another and improved final recanalization rates when used successively.
鉴于新型 Embolus 取栓器与互连式网篮(ERIC)在较小病例系列中的出色表现,我们旨在评估 ERIC 与其他支架取栓器(SR)治疗急性缺血性卒中(AIS)伴大血管闭塞(LVO)的疗效和安全性。
我们回顾了德国和瑞士两家综合卒中中心数据库中,因前循环 LVO 而行机械血栓切除术(MT)的病例,纳入患者均采用 ERIC 或其他 SR 作为首用装置。主要结局定义为首次装置后成功再通(血栓切除术溶栓分级 2b/3)和 90 天随访时良好结局(改良 Rankin 量表评分 0-2)。采用多变量逻辑回归分析调整潜在混杂因素。
183 例 AIS 患者接受 ERIC(49%)或 SR(51%)作为首用装置治疗,再通率分别为 82%和 57%(P<0.001)。在无效 ERIC 再通时加入 SR,或反之,可提高最终再通率(ERIC:87%,SR:79%)。采用 ERIC 作为首用装置的患者中,50%的临床结局良好,而采用 SR 时为 35%(P=0.038),该结果与年龄、卒中严重程度、颈内动脉-椎动脉闭塞、全身麻醉以及装置类型有关,与再通率无关。
采用 ERIC 作为首用装置似乎与更高的再通率相关,并可获得更好的功能结局。然而,良好结局并非归因于 ERIC。最重要的是,这两种装置类型可以相互补充,且序贯使用可提高最终再通率。